Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas

Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas

Abstract Background A gel‐free proteomic approach was utilized to perform in‐depth tissue protein profiling of lung adenocarcinoma (ADC) and normal lung tissues from early and advanced stages of the disease. The long‐term goal of this study is to generate a large‐scale, label‐free proteomics dataset...

Full description

Bibliographic Details
Main Authors: Olga Kelemen, Indira Pla, Aniel Sanchez, Melinda Rezeli, Attila Marcell Szasz, Johan Malm, Viktoria Laszlo, Ho Jeong Kwon, Balazs Dome, Gyorgy Marko‐Varga
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical and Translational Medicine
Subjects:
clinical proteomics
lung adenocarcinomas
mass spectrometry
proteomics
Online Access:https://doi.org/10.1002/ctm2.106

Internet

https://doi.org/10.1002/ctm2.106

Similar Items